4 minute read
Sep. 28, 2022

Obicetrapib: an Oral Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor for Dyslipidemia

obicetrapib

oral CETP inhibitor Ph. III candidate in cardiology Signif. lipid lowering effect at 5 mg PO QD Nat. Med. NewAmsterdam Pharma B.V., Naarden, NL (Amgen)

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in